OCU-OMEGA
Natural health product licensed in Canada
- Licence holder
- Douglas Laboratories Canada
- NPN or DIN-HM
- 80031087
- Status
- Inactive licence
- Licence date
- 30 March 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| (3R,3'R)-Dihydroxy-beta-carotene Source : L'oléorésine de Tagetes erecta | 0.6 mg | Not calculated |
| (3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol Source : L'oléorésine de Tagetes erecta | 3.3 mg | Not calculated |
| Huile de poisson Source : Body oil from Sardine & Anchovy Potency : 116.7 mg DHA (docosahexaenoic acid) | 400 mg | Not calculated |
| Huile de poisson Source : Body oil from Sardine & Anchovy Potency : 216.6 mg EPA (eicosapentaenoic acid) | Not specified | Not calculated |
| Huile de poisson Source : Herring body oil Potency : 116.7 mg DHA (docosahexaenoic acid) | 400 mg | Not calculated |
| Huile de poisson Source : Herring body oil Potency : 216.6 mg EPA (eicosapentaenoic acid) | Not specified | Not calculated |
| Huile de poisson Source : Huile provenant de la chair de Saumon Potency : 116.7 mg DHA (docosahexaenoic acid) | 400 mg | Not calculated |
| Huile de poisson Source : Huile provenant de la chair de Saumon Potency : 216.6 mg EPA (eicosapentaenoic acid) | Not specified | Not calculated |
Non-medicinal ingredients
Mélange de concentré de tocophérols, Acid citrique, Palmitate d'ascorbyle, Gélatine, Extrait de romarin, Huile de carthame
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Capsule | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Antioxidant for the maintenance of good health. Source of omega-3 fatty acids for the maintenance of good health. Helps maintain/support cardiovascular health. Helps to reduce serum triglycerides/triacylglycerols. Source of eicosapentaenoic acid EPA and docosahexaenoic acid. Helps support cognitive health and/or brain function. Antioxidant for the maintenance of eye health. Helps to maintain eyesight in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment optical density.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80031087
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.